Harel Insurance Investments & Financial Services’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio AYLA Stock Details AYLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,153,273	Closed	-$862K	–	751
2022 Q4	$862K	Hold	2,153,273	–	–	0.02%	163
2022 Q3	$2.15M	Hold	2,153,273	–	–	0.05%	128
2022 Q2	$2.35M	Sell	2,153,273 -587	-0%	-$1.34K	0.05%	129
2022 Q1	$8.57M	Buy	2,153,860 +212	+0%	+$1.1K	0.14%	90
2021 Q4	$18.3M	Buy	2,153,648 +2,153,118	+406,249%	+$21.4M	0.35%	58
2021 Q3	$6K	Buy	530 +72	+16%	+$864	﹤0.01%	650
2021 Q2	$5K	Buy	+458	New	+$4.7K	﹤0.01%	749

Harel Insurance Investments & Financial Services's AYLA Position: Q1 2023 in Review

Harel Insurance Investments & Financial Services sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q1 2023, closing a stake of 2,153,273 shares — an estimated $862K sold.

Harel Insurance Investments & Financial Services first reported a position in AYLA in Q2 2021 and held it in 7 quarters. The position peaked at $18.3M in Q4 2021. 0 funds tracked by Wall St. Rank hold AYLA as of Q1 2023.

Harel Insurance Investments & Financial Services reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Harel Insurance Investments & Financial Services sold 2,153,273 Ayala Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $862K.
Harel Insurance Investments & Financial Services first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 7 quarters.
Harel Insurance Investments & Financial Services's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $18.3M in Q4 2021.
0 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2023, filed 2 May 2023.